IA SSB3115

Requires physicians to perform an in-person examination of a pregnant woman prior to an abortion, including screening for indicia of coercion or abuse, and to refer the woman to appropriate health care providers if necessary.

Mandates that before prescribing or dispensing an abortion-inducing drug, a physician must obtain the patient's signature on the FDA patient agreement form and obtain written confirmation the woman has been informed of specific risks including hemorrhage, incomplete abortion, sepsis, sterility, and possible continuation of pregnancy.

Requires physicians to inform patients that it may be possible to reverse the effects of a chemical abortion and that reversal information is available on the state department's website; the department must publish chemical abortion reversal information online.

Establishes reporting requirements for abortion-inducing drug complications, requiring health care providers to report complications to the Iowa Department of Health and Human Services, and requires the department to publish annual statistical reports on such complications.

Subjects physicians who fail to comply with the informed consent, dispensing, or reporting requirements to licensee discipline under the Iowa Board of Medicine (chapter 148), while explicitly providing that no civil or criminal liability shall be imposed on the woman upon whom a chemical abortion has been performed.